Target intelligence / Profile preview

LRR binding FLII interacting protein 1 pseudogene 1 (LRRFIP1P1)

Target
LRRFIP1P1
Molecular classification
Other (processed pseudogene)
01

Overview

LRRFIP1P1 is a processed pseudogene in the human genome with high sequence similarity to the functional gene LRR binding FLII interacting protein 1 (LRRFIP1). As a pseudogene, LRRFIP1P1 does not encode a functional protein product. Pseudogenes can sometimes regulate their parent gene by acting as competing endogenous RNAs (ceRNAs) or miRNA sponges, affecting the stability and translation of the original gene's mRNA, but this specific role has not been documented for LRRFIP1P1. Its designation as a pseudogene means it lacks the canonical molecular functions or disease associations typical of drug targets, and it is not included among therapeutic targets in pharmacology or drug development resources. LRRFIP1P1 should not be regarded as a receptor, enzyme, transporter, or any other kind of canonical drug target. Its utility or importance, if any, relates only to genomics or possible regulatory RNA roles yet to be demonstrated specifically for this pseudogene. There are no known drugs, mechanisms, or diagnostic implications tied specifically to LRRFIP1P1.

02

Biological functions

May participate in regulation of parent gene expression via noncoding RNA-based mechanisms such as miRNA decoy or transcript sponging, but no such data exists specifically for LRRFIP1P1

Beyond the preview

Go deeper on LRR binding FLII interacting protein 1 pseudogene 1 (LRRFIP1P1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on LRR binding FLII interacting protein 1 pseudogene 1 (LRRFIP1P1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call